New Developments in Chronic Myeloid Leukemia
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 18
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue aims to highlight the latest advancements in the understanding and management of chronic myeloid leukemia (CML). Contributions will cover a wide spectrum of topics, ranging from the etiology and epidemiology of the disease to emerging strategies in diagnosis and treatment.
Key focus areas include the following:
- Etiology and Epidemiology:
Insights into the causes, risk factors, and global trends in CML incidence. - Diagnostic Advances:
- Identification of novel molecular and clinical markers.
- Improvements in early detection and prognostic evaluation.
- Role of genetic alterations and chromosomal abnormalities in disease progression.
- Therapeutic Innovations:
- Development and optimization of small-molecule Tyrosine Kinase Inhibitors (TKIs) as first-line treatments.
- Exploration of biological therapies such as allogeneic stem cell transplantation and Interferon-alpha.
- Emerging strategies in chemotherapy and supportive care.
- Results from clinical trials and therapies currently in the development pipeline.
This Special Issue welcomes original research articles, reviews, and short communications that contribute to the evolving landscape of CML research and clinical practice. We hope to provide a comprehensive overview of the most promising directions in the fight against CML.
Dr. Parviz Kokhaei
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- CML
- small molecule inhibitors
- biologicall treatment
- prognostic markers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
